Synplogen Co., Ltd.

Synplogen Co., Ltd.

Private
KobeHealthcare & Life Scienceshttps://www.synplogen.com

Last Round

Series D

Jan 27, 2025

Total Funding Raised

$29.53M

Company Overview

Synplogen Co., Ltd. is a biotechnology company that provides DNA synthesis, DNA library construction, and gene therapy biofoundry services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

DNA synthesissynthetic biologylong-chain DNA synthesisgene synthesisCDMObiofoundrycustom DNA synthesissynthetic DNAgene therapyCMC servicesContract Development and Manufacturing OrganizationDNA library constructionviral vector manufacturingplasmid DNA manufacturingmRNA manufacturingChemistry, Manufacturing, and Controls

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synplogen Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synplogen Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJan 27, 2025
Series C ExtensionFeb 28, 2023
Series CDec 9, 2022
Series B ExtensionDec 27, 2021
Series BNov 30, 2021
Series A
May 30, 2019

Synplogen Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 22, 2025

    Added Iwai Chem, a Chemicals/Life Sciences Distribution SMB, as a customer.

Synplogen Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synplogen Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synplogen Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKobe
Employee Range3
Year Founded2017
Last FundingJan 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.